Zoetis reported Q2 revenue of $2.5 billion, roughly flat compared to the same period last year, according to an SEC Form 8-K filing dated August 6 (local time).
📊 Price at time of writing (August 6, 2026, 9:08 PM KST)
$74.39 ▼ -2.17%
Down 2.17% from the previous close
This Quarter's Results at a Glance
Q2 revenue held essentially flat at $2.5 billion, weighed down by softer demand for pet-care products as veterinary visits declined and consumers grew more price-sensitive. Adjusted earnings per share, however, topped Wall Street estimates.
- Revenue: $2.5 billion, roughly in line with the year-ago period (down 1% organically, ex-currency)
- Net income: $691 million, down 5% year-over-year
- Earnings per share (EPS): $1.65, up 1% year-over-year
- Adjusted net income: $781 million, down 1% year-over-year
- Adjusted EPS: $1.87, above the $1.85 consensus estimate
Outlook for Coming Quarters
Zoetis lowered its full-year 2026 revenue guidance to a range of $9.12 billion to $9.32 billion. On an organic, ex-currency basis, the company expects revenue to decline 1% to 3%. Adjusted EPS guidance was also cut, to a range of $6.15 to $6.25. CEO Kristin Peck said, 'Fewer veterinary visits and heightened price sensitivity have weighed on demand across parts of our portfolio,' adding that the company is 'adjusting its business strategy to match current market conditions.'
Market Reaction
Following the earnings release, Zoetis shares fell 2.17% to $74.39 as of 9:08 PM KST on August 6, 2026. While adjusted EPS beat expectations, the lowered full-year guidance and softness in the pet-care segment appear to have weighed on investor sentiment.
Segment Breakdown
- U.S. segment revenue: $1.3 billion, down 7% year-over-year (companion animal product revenue down 11%, livestock products up 23%)
- International segment revenue: $1.2 billion, up 8% year-over-year (companion animal product revenue up 8%, livestock products also up 8%)
This article was automatically generated based on the original SEC Form 8-K filing and wire reports, with the goal of delivering key data promptly after the announcement. Readers are advised to consult the company's official disclosure before making trading decisions. Prices reflect the time of writing and may differ from current market levels.
